SCHEMBL15214866

SCHEMBL15214866

Ic1ccc(-c2cn[nH]c2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT2 P31751 10/20 0.61
AKT1 P31749 6/20 0.61
METAP2 P50579 1/20 0.50
ROCK2 O75116 3/20 0.46
ACVR1 Q04771 1/20 0.44
MAPK1 P28482 1/20 0.43
AKT3 Q9Y243 3/20 0.42
PRKACA P17612 2/20 0.42
PRKCD Q05655 2/20 0.42
RPS6KA5 O75582 1/20 0.42
RPS6KA4 O75676 1/20 0.42
LATS1 O95835 1/20 0.42
PRKACB P22694 1/20 0.42
RPS6KB1 P23443 1/20 0.42
GRK2 P25098 1/20 0.42
RPS6KA3 P51812 1/20 0.42
ROCK1 Q13464 1/20 0.42
RPS6KA2 Q15349 1/20 0.42
RPS6KA1 Q15418 1/20 0.42
PKN1 Q16512 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16432987 0.88 AKT2 (0.76) AKT2AKT1ROCK2ACVR1AKT3
SCHEMBL15689115 0.88 AKT2 (0.76) AKT2AKT1ROCK2ACVR1AKT3
SCHEMBL3740850 0.80 AKT2 (0.70) AKT2AKT1ROCK2ACVR1MAPK1
SCHEMBL16872766 0.79 AKT2 (0.95) AKT2AKT1ROCK2PIM1ILK
SCHEMBL104535 0.77 AKT2 (0.61) AKT2AKT1ROCK2ACVR1ROCK1
SCHEMBL15504532 0.77 AKT2 (0.61) AKT2AKT1METAP2ROCK2ACVR1
SCHEMBL844167 0.77 AKT2 (0.61) AKT2AKT1METAP2ROCK2ACVR1
SCHEMBL28424886 0.77 AKT2 (0.61) AKT2AKT1ROCK2ACVR1AKT3
SCHEMBL20588075 0.77 AKT2 (0.61) AKT2AKT1ROCK2ACVR1AKT3
SCHEMBL4582237 0.77 AKT2 (0.61) AKT2AKT1ROCK2ACVR1AKT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016112236-A1 CYCLIC UREAS AS INHIBITORS OF ROCK BRISTOL-MYERS SQUIBB COMPANY (US) 2016-07-14 WO disclosed
US-8518970-B2 Compounds and methods of use ABBVIE INC. (US) 2013-08-27 US disclosed